US Aid Cuts Expose Ghana’s Vaccination Achilles Heel

The suspension of USAID programmes has sent shockwaves through Ghana’s health sector, leaving a significant funding gap that threatens the country’s impressive progress in child immunisation. The $78.2m shortfall in health funding is a stark reminder that even well-intentioned development efforts can be undermined by international donors’ whims.

Ghana’s success with the RTS,S malaria vaccine has been hailed as a model for other African countries, with a 13% reduction in mortality among children eligible for vaccination. The dedication and resourcefulness of health workers who have worked tirelessly to reach remote communities and ensure vaccines are delivered safely have also played a crucial role.

However, the disruption caused by USAID programme closures has exposed deep-seated vulnerabilities in Ghana’s healthcare system. A study examining donor withdrawal in northern Ghana found that 75% of districts surveyed reported vaccine delays or irregular supplies, highlighting the fragility of the country’s immunisation infrastructure.

Private sector leaders are stepping forward to offer support and solutions. John Yabani, medical director of Banahene Specialist Hospital, and Nana Owusu Ensaw, municipal director of health for Akuapim North, believe that Ghana can attract patients from across West Africa and beyond by investing in diagnostics, telemedicine, and specialist care.

However, while private investment is essential for building a resilient healthcare system, it cannot immediately replace the public health infrastructure needed to deliver routine vaccinations. In remote communities where health teams face significant challenges in reaching families and delivering vaccines, the loss of donor funding could have devastating consequences.

Government officials see the USAID cut as an opportunity for Africa to take control of its own healthcare needs. They argue that this moment represents a chance to put their house in order and utilise local resources to ensure citizens are protected against preventable diseases. George Kwame Egeh, cofounder and director of operations at the Humserve Africa Foundation, believes that civil society organisations can step in to fill the funding gap created by USAID cuts.

For families living in communities that struggle to access healthcare services, these debates may seem like distant abstractions. They know that their children’s lives are on the line as health teams face mounting pressures to deliver vaccines safely and efficiently. Mark Appiah, chairman of the Oti Regional Health Committee, warns: “A child should not lose protection against a preventable disease because the health system is experiencing a financing problem.”

Ghana must avoid getting caught in a trap of dependency on external aid. The country’s accelerated transition from Gavi support and its growing reliance on local funding are steps in the right direction, but they also underscore the need for a long-term strategy that prioritises domestic resource mobilisation and community participation.

This crisis presents Ghana with an opportunity to rethink its approach to healthcare financing. By investing in local resources, building structured partnerships with businesses, development partners, and NGOs, and prioritising targeted support for hard-to-reach communities, the country can create a health system that is truly world-class. The question now is whether Ghana will seize this moment or falter under the pressure of external funding uncertainties.

Rahinatu, a mother from northern Ghana who has benefited from routine immunisation, remains optimistic: “I am hopeful the government will figure a homegrown solution as soon as possible to get things back on track for us.” Her hope is not misplaced – Ghana’s future depends on it.